These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9273523)

  • 1. [Use of human anti-Pseudomonas immunoglobulins in treatment of children with burns].
    Bukowska D; Wegrzynowicz Z; Rudowski W; Kraj M; Rosiek A; Gardzińska E; Popiel D
    Pol Tyg Lek; 1996 Jun; 51(23-26):331-3. PubMed ID: 9273523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
    Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Pseudomonas immunoglobulin. IV. Combined anti-Pseudomonas immunoglobulin and Pseudomonas vaccine immunotherapy of burned patients--clinical investigations.
    Sakiel S; Schiller B; Buchowicz I; Lysakowska E; Tomanek E; Kruczałowa M; Przewdziecka M
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):523-8. PubMed ID: 6534319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive anti-PcrV treatment protects burned mice against Pseudomonas aeruginosa challenge.
    Neely AN; Holder IA; Wiener-Kronish JP; Sawa T
    Burns; 2005 Mar; 31(2):153-8. PubMed ID: 15683685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi.
    Roe EA; Jones RJ
    Rev Infect Dis; 1983; 5 Suppl 5():S922-30. PubMed ID: 6419315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
    Roe EA; Jones RJ
    Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
    Zellner PR; Zwissler O; Metzger E
    Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
    Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1980 Dec; 2(8207):1263-5. PubMed ID: 6108445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN; Holder IA
    Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.
    Meitert T; Meitert E; Szegli G; Peligrad I
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):115-21. PubMed ID: 6816189
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pyocyanic infection in burned patients. Immunitary protection].
    Moyen EN; Lesage D; Romano P
    Nouv Presse Med; 1972 Apr; 1(14):947-50. PubMed ID: 4623061
    [No Abstract]   [Full Text] [Related]  

  • 15. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of 240 cases of burn patients with Pseudomonas aeruginosa septicemia].
    Yang XD
    Zhonghua Wai Ke Za Zhi; 1989 May; 27(5):292-3, 317. PubMed ID: 2806007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention using a Pseudomonas immunoglobulin in burn patients].
    Stuttmann R; Petrovici V; Hartert M
    Infection; 1987; 15(1):80-4. PubMed ID: 3106234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reduction of Pseudomonas septicemias in burned patients by the immune process.
    Pierson C; Feller I
    Surg Clin North Am; 1970 Dec; 50(6):1377-83. PubMed ID: 4922825
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severely burned patients: epidemiology and treatment (a study of 104 Gabonese cases)].
    Nguema PN; Matsiegui PB; Nsafu DN
    Sante; 2000; 10(1):37-42. PubMed ID: 10827361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocarditis in burn patients: clinical and diagnostic considerations.
    Regules JA; Glasser JS; Wolf SE; Hospenthal DR; Murray CK
    Burns; 2008 Aug; 34(5):610-6. PubMed ID: 18029099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.